Hepatitis C Drugs Boost Remdesivir’s Antiviral Activity Against COVID-19

April 27, 2021 • by Marc Airhart
drawing of a hand holding a pill

Drugs used to treat hepatitis C render remdesivir 10 times better at inhibiting the coronavirus in cell cultures, according to new study. Illustration credit: Jenna Luecke/University of Texas at Austin.


Share


A close-up microscope image of a bacterium that has collapsed and spilled its contents

LaMontagne Center for Infectious Disease

Re-engineered Antibodies Kill Bacteria Directly